Laxatives Market Analysis and Global Forecast 2023-2033

$ 1,390.00$ 5,520.00

Laxatives Market Research Report: Information By Drug Type (Hyperosmotic and Bulk-Forming), By Route of Administration (Oral and Rectal), By Indication (Chronic Constipation and Irritable Bowel Syndrome), By End User (Hospitals & Clinics, Research Institutes, and Others), and Region — Forecast till 2033

Report Published on: October 19, 2024
$ 3,470.00
$ 5,520.00
$ 1,390.00
Report Code: EBI52245 Categories: , ,
Description

The Global Laxatives Market size is projected to reach approximately USD 16.77 Billion by 2033, at a CAGR of 5.76% from 2023 to 2033. The laxatives refer to the global market for products that are used to relieve constipation and promote bowel movements. Laxatives are substances or medications that help stimulate bowel movements or soften the stool, making it easier to pass through the intestines and alleviate constipation, which is a condition characterized by infrequent or difficult bowel movements. The laxatives market includes a wide range of products, including over-the-counter (OTC) laxatives, prescription laxatives, and natural or herbal laxatives. These products are available in various forms, such as oral tablets, capsules, powders, liquids, suppositories, and enemas. Laxatives may contain different active ingredients that work through different mechanisms, such as increasing stool bulk, softening the stool, lubricating the intestines, or stimulating the muscles of the intestines to contract.

Laxatives Market AnalysisCOVID-19 Impact Analysis

The COVID-19 pandemic had a significant impact on the laxatives market, with increased demand, supply chain disruptions, changing consumer behavior, and a shift towards self-care and e-commerce being notable trends. It is important to note that the impact may vary across regions and over time as the pandemic situation evolve.

Laxatives Market Analysis Market Dynamics

The Factor affecting the overall Laxatives market as described below:

Drivers:

Increasing prevalence of constipation due to sedentary lifestyles

Sedentary lifestyles are often associated with poor dietary habits, such as low fiber intake, inadequate hydration, and increased consumption of processed and low-nutrient foods. These dietary factors can further increase the risk of constipation by affecting stool consistency, bowel transit time, and overall gut health. As a result, the increasing prevalence of constipation due to sedentary lifestyles can drive the demand for laxatives and related products in the market. Many individuals may turn to laxatives as a short-term solution to relieve constipation and promote regular bowel movements. This, in turn, can contribute to the growth of the laxatives market as more people seek relief from constipation caused by sedentary lifestyles.

Restraint:

  • Changing Consumer Preferences and Behavior

Consumer preferences and behavior are constantly evolving, and there may be shifts in consumer preferences towards other forms of digestive health management, such as dietary supplements, probiotics, or lifestyle changes. Changing consumer preferences and behavior may impact the demand for laxatives and restrain the market growth.

Opportunity:

Increasing Awareness about Digestive Health

Awareness about the importance of digestive health and the impact of constipation on overall well-being is growing among consumers. Increased education and awareness campaigns by healthcare providers, pharmaceutical companies, and other stakeholders can create opportunities for the laxatives market by driving consumer demand for products that help manage digestive health.

Laxatives Market Analysis Segment Overview

Laxatives Market Drug Type AnalysisBy Drug Type

Based on the Drug Type, the Laxatives market is segmented based on Hyperosmotic and Bulk-Forming. The Hyperosmotic segment is expected to hold the largest market share, This is due to several factors, such as their effectiveness in treating constipation, wide availability over-the-counter (OTC) without a prescription, and relatively fewer side effects compared to some other types of laxatives.

By Route of Administration

Based on the Route of Administration, the global Laxatives market has been divided into Oral and Rectal. The Oral segment is expected to hold the largest market share. As oral laxatives are preferred by many patients due to their non-invasive nature compared to other types of laxatives, such as rectal suppositories or enemas, which may be less comfortable or convenient for some individuals.

By Indication

Based on Indication, the global Laxatives market has been divided into Chronic Constipation and Irritable Bowel Syndrome. The Chronic Constipation segment is expected to hold the largest market share. This is because chronic constipation is a common condition that affects a significant portion of the population, especially among the older People, individuals with certain medical conditions, and those on certain medications. Chronic constipation can have a significant impact on quality of life, leading to a demand for effective and convenient treatment options.

By End User

Based on End Users, the global Laxatives market has been divided into Hospitals & Clinics, Research Institutes, and Others. The Hospitals & Clinics segment holds the largest market share of Laxatives. Hospitals and clinics often serve as the primary source of medical care for individuals with severe or chronic constipation, who may require more specialized treatment options or closer medical supervision.

Global Laxatives Market Share, by Segmentation

Laxatives Market Regional Analysis

Based on region, the global Laxatives market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the Laxatives market followed by the Asia-Pacific and Europe regions.

North America Market

North America has historically been one of the dominant regions in the laxatives market. The laxatives market refers to the global market for products that are used to relieve constipation and promote bowel movements. Several factors contribute to North America’s dominance in the laxatives market. One of the key factors is the high prevalence of constipation and gastrointestinal disorders in North America, which drives the demand for laxatives. Unhealthy dietary habits, sedentary lifestyles, and other lifestyle factors can contribute to constipation, leading to a higher demand for laxative products.

Europe Market

Europe is indeed one of the major regions in the global laxatives market. The laxatives market in Europe is driven by various factors such as the increasing prevalence of constipation and other gastrointestinal disorders, changing lifestyles and dietary habits, the growing aging population, and increasing awareness about gastrointestinal health. Several types of laxatives are available in the market, including bulk-forming laxatives, stimulant laxatives, osmotic laxatives, and others. These laxatives are used for different purposes and work in different ways to relieve constipation and promote bowel movements.

Competitive Landscape

The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Since of their strategic innovations and broad regional presence, companies such as Sanofi, Pfizer Inc, GlaxoSmithKline, and Novartis lead the global Laxatives business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.

Prominent Players:

  • Hoffmann-La Roche Ltd
  • Mylan
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • Pfizer Inc
  • GlaxoSmithKline
  • Novartis
  • Merck & Co Inc
  • AstraZeneca
  • Johnson & Johnson Private Limited

Scope of the Report

Global Laxatives Market, by Drug Type

  • Hyperosmotic
  • Bulk-Forming

Global Laxatives Market, by Route of Administration

  • Oral
  • Rectal

Global Laxatives Market, by Indication

  • Chronic Constipation
  • Irritable Bowel Syndrome

Global Laxatives Market, by End User

  • Hospitals & Clinics
  • Research Institutes
  • Others

Global Laxatives Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the World

 

Parameters Indicators
Market Size 2033: $ 16.77 Billion
CAGR 5.76% CAGR (2023-2033)
Base year 2022
Forecast Period 2023-2033
Historical Data 2021
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Drug Type, Route of Administration, Indication, End User
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors F. Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GlaxoSmithKline, Novartis, Merck & Co Inc, AstraZeneca, Johnson & Johnson Private Limited
Key Market Opportunities Increasing Awareness about Digestive Health
Key Market Drivers Increasing prevalence of constipation due to sedentary lifestyles

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Laxatives market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Laxatives market historical market size for the year 2021, and forecast from 2023 to 2033
  • Laxatives market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Laxatives market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

 

For more details mail us at

Ask a question / additional requirement

Frequently Asked Questions (FAQ)

The global Laxatives market is growing at a CAGR of ~ 76% over the next 10 years

Europe is expected to register the highest CAGR during 2023-2033

North America holds the largest share in 2022

Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GlaxoSmithKline, Novartis, Merck & Co Inc, AstraZeneca, Johnson & Johnson Private Limited are the major companies operating in the global Laxatives market.

Yes, we offer 16 hours of analyst support to solve the queries

Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

Table of Content

Table of Content

Chapter 1.   Executive Summary

Chapter 2.   Scope Of Study

                     2.1.   Market Definition

                     2.2.   Scope Of The Study

                               2.2.1.   Objectives of Report

                               2.2.2.   Limitations

                     2.3.   Market Structure

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                               4.1.1.   Raw Application Providers

                               4.1.2.   Manufacturing Process

                               4.1.3.   Distributors/Retailers

                               4.1.4.   End Users

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat Of New Entrants

                               4.2.2.   Bargaining Power Of Buyers

                               4.2.3.   Bargaining Power Of Suppliers

                               4.2.4.   Threat Of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact Of COVID-19 on the Laxatives Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End-User Trend, Preferences, and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players' Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

                     4.4.   Technology Overview

                     4.5.   Macro factor

                     4.6.   Micro Factor

                        4.7.   Demand Supply Gap Analysis of the Laxatives Market

                        4.8.   Import Analysis of the Laxatives Market

                        4.9.   Export Analysis of the Laxatives Market

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DROC Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

                               5.2.4.   Challenges

                     5.3.   Patent Analysis

                     5.4.   Industry Roadmap

                     5.5.   Parent/Peer Market Analysis

Chapter 6.   Global Laxatives Market, By Drug Type

                     6.1.   Introduction

                     6.2.   Hyperosmotic

                     6.3.  Bulk-Forming

Chapter 7.   Global Laxatives Market, By Route of Administration

                     7.1.   Introduction

                     7.2.   Oral

                     7.3.   Rectal

Chapter 8.   Global Laxatives Market, By Indication

                     8.1.   Introduction

                     8.2.   Chronic Constipation

                     8.3.  Irritable Bowel Syndrome

Chapter 9.   Global Laxatives Market, By End User

                     9.1.   Introduction

                     9.2.   Hospitals & Clinics

                     9.3.   Research Institutes

                     9.4.   Others

Chapter 10.   Global Laxatives Market, By Region

                     10.1.   Introduction

                     10.2.   North America

                               10.2.1.   Introduction

                               10.2.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               10.2.3.   Market Size and Forecast, By Country, 2023-2033

                               10.2.4.   Market Size and Forecast, By Drug Type, 2023-2033

                               10.2.5.   Market Size and Forecast, By Route of Administration, 2023-2033

                               10.2.6.   Market Size and Forecast, By Indication, 2023-2033

                               10.2.7.   Market Size and Forecast, By End User, 2023-2033

                               10.2.8.   US

                                              10.2.8.1.   Introduction

                                              10.2.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.2.8.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.2.8.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.2.8.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.2.8.6.   Market Size and Forecast, By End User, 2023-2033

                               10.2.9.   Canada

                                              10.2.9.1.   Introduction

                                              10.2.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.2.9.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.2.9.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.2.9.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.2.9.6.   Market Size and Forecast, By End User, 2023-2033

                     10.3.   Europe

                               10.3.1.   Introduction

                               10.3.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               10.3.3.   Market Size and Forecast, By Country, 2023-2033

                               10.3.4.   Market Size and Forecast, By Drug Type, 2023-2033

                               10.3.5.   Market Size and Forecast, By Route of Administration, 2023 – 2030

                               10.3.6.   Market Size and Forecast, By Indication, 2023-2033

                               10.3.7.   Market Size and Forecast, By End User, 2023 – 2030

                               10.3.8.   Germany

                                              10.3.8.1.   Introduction

                                              10.3.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.3.8.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.3.8.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.8.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.8.6.   Market Size and Forecast, By End User, 2023-2033

                               10.3.9.   France

                                              10.3.9.1.   Introduction

                                              10.3.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.3.9.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.3.9.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.9.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.9.6.   Market Size and Forecast, By End User, 2023-2033

                               10.3.10.   UK

                                              10.3.10.1.   Introduction

                                              10.3.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.3.10.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.3.10.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.10.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.10.6.   Market Size and Forecast, By End User, 2023-2033

                               10.3.11.   Italy

                                              10.3.11.1.   Introduction

                                              10.3.11.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.3.11.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.3.11.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.11.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.11.6.   Market Size and Forecast, By End User, 2023-2033

                               10.3.12.   Rest Of Europe

                                              10.3.12.1.   Introduction

                                              10.3.12.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.3.12.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.3.12.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.12.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.12.6.   Market Size and Forecast, By End User, 2023-2033

                     10.4.   Asia-Pacific

                               10.4.1.   Introduction

                               10.4.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               10.4.3.   Market Size and Forecast, By Country, 2023-2033

                               10.4.4.   Market Size and Forecast, By Drug Type, 2023-2033

                               10.4.5.   Market Size and Forecast, By Route of Administration, 2023-2033

                               10.4.6.   Market Size and Forecast, By Indication, 2023-2033

                               10.4.7.   Market Size and Forecast, By End User, 2023-2033

                               10.4.8.   China

                                              10.4.8.1.   Introduction

                                              10.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.4.8.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.4.8.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.3.8.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.3.8.6.   Market Size and Forecast, By End User, 2023-2033

                               10.4.8.   India

                                              10.4.8.1.   Introduction

                                              10.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.4.8.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.4.8.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.4.8.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.4.8.6.   Market Size and Forecast, By End User, 2023-2033

                               10.4.9.   Japan

                                              10.4.9.1.   Introduction

                                              10.4.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.4.9.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.4.9.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.4.9.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.4.9.6.   Market Size and Forecast, By End User, 2023-2033

                               10.4.10.   South Korea

                                              10.4.10.1.   Introduction

                                              10.4.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.4.10.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.4.10.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.4.10.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.4.10.6.   Market Size and Forecast, By End User, 2023-2033

                               10.4.11.   Rest Of Asia-Pacific

                                              10.4.11.1.   Introduction

                                              10.4.11.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.4.11.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.4.11.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.4.11.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.4.11.6.   Market Size and Forecast, By End User, 2023-2033

                     10.5.   Rest Of The World (RoW)

                               10.5.1.   Introduction

                               10.5.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               10.5.3.   Market Size and Forecast, By Drug Type, 2023-2033

                               10.5.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                               10.5.5.   Market Size and Forecast, By Indication, 2023-2033

                               10.5.6.   Market Size and Forecast, By End User, 2023-2033

                               10.5.7.   Market Size and Forecast, By Region, 2023-2033

                               10.5.8.   South America

                                              10.5.8.1.   Introduction

                                              10.5.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.5.8.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.5.8.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.5.8.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.5.8.6.   Market Size and Forecast, By End User, 2023-2033

                               10.5.9.   Middle East and Africa

                                              10.5.9.1.   Introduction

                                              10.5.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              10.5.9.3.   Market Size and Forecast, By Drug Type, 2023-2033

                                              10.5.9.4.   Market Size and Forecast, By Route of Administration, 2023-2033

                                              10.5.9.5.   Market Size and Forecast, By Indication, 2023-2033

                                              10.5.9.6.   Market Size and Forecast, By End User, 2023-2033

Chapter 11.   Competitive Landscape

                     11.1.   Introduction

                     11.2.   Vendor Share Analysis, 2022/Key Players Positioning, 2022

Chapter 12.   Company Profiles

                     12.1.   F. Hoffmann-La Roche Ltd

                               12.1.1.   Business Overview

                               12.1.2.   Financial Analysis

                               12.1.3.   Product Portfolio

                               12.1.4.   Recent Development and Strategies Adopted

                               12.1.5.   SWOT Analysis

                     12.2.  Mylan

                               12.2.1.   Business Overview

                               12.2.2.   Financial Analysis

                               12.2.3.   Product Portfolio

                               12.2.4.   Recent Development and Strategies Adopted

                               12.2.5.   SWOT Analysis

                     12.3.   Teva Pharmaceutical Industries Ltd

                               12.3.1.   Business Overview

                               12.3.2.   Financial Analysis

                               12.3.3.   Product Portfolio

                               12.3.4.   Recent Development and Strategies Adopted

                               12.3.5.   SWOT Analysis

                     12.4.   Sanofi

                               12.4.1.   Business Overview

                               12.4.2.   Financial Analysis

                               12.4.3.   Product Portfolio

                               12.4.4.   Recent Development and Strategies Adopted

                               12.4.5.   SWOT Analysis

                     12.5.   Pfizer Inc

                               12.5.1.   Business Overview

                               12.5.2.   Financial Analysis

                               12.5.3.   Product Portfolio

                               12.5.4.   Recent Development and Strategies Adopted

                               12.5.5.   SWOT Analysis

                     12.6.   GlaxoSmithKline

                               12.6.1.   Business Overview

                               12.6.2.   Financial Analysis

                               12.6.3.   Product Portfolio

                               12.6.4.   Recent Development and Strategies Adopted

                               12.6.5.   SWOT Analysis

                     12.7.   Novartis

                               12.7.1.   Business Overview

                               12.7.2.   Financial Analysis

                               12.7.3.   Product Portfolio

                               12.7.4.   Recent Development and Strategies Adopted

                               12.7.5.   SWOT Analysis

                     12.8.   Merck & Co

                               12.8.1.   Business Overview

                               12.8.2.   Financial Analysis

                               12.8.3.   Product Portfolio

                               12.8.4.   Recent Development and Strategies Adopted

                               12.8.5.   SWOT Analysis

                     12.9.   AstraZeneca

                               12.9.1.   Business Overview

                               12.9.2.   Financial Analysis

                               12.9.3.   Product Portfolio

                               12.9.4.   Recent Development and Strategies Adopted

                               12.9.5.   SWOT Analysis

                     12.10.   Johnson & Johnson Private Limited

                               12.10.1.   Business Overview

                               12.10.2.   Financial Analysis

                               12.10.3.   Product Portfolio

                               12.10.4.   Recent Development and Strategies Adopted

                               12.10.5.   SWOT Analysis

              Chapter 13.   Key Takeaways

 

 

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology